Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Mar 26, 2022; 10(9): 2721-2732
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2721
Table 4 Primary and secondary outcomes
Spinal anaesthesia (n = 206)
General anaesthesia (n = 103)
P value

n/mean
%/SD
n/mean
%/SD

Length of hospital stay (d)12.544.5813.315.050.212
90-d readmission 209.71110.70.789
Clavien-Dindo score0.583
112661.26563.1
26933.53029.1
310.500
4104.987.8
50000
Renal function
GLU (mmoL l-1)18.062.777.402.360.006
Urea (mmoL l-1)7.343.277.463.730.943
Cr (μmoL l-1)92.4359.3983.4736.250.822
eGFR (mL min-1/1.73 m2)63.8721.5465.6720.540.656
ALB (g)31.283.2832.013.920.148
Routine blood
WBC (109 l-1)110.763.1610.002.770.033
NEUT (%)82.416.0881.386.160.170
RBC (1012 l-1)3.310.553.845.570.753
Hb (g l-1)95.0715.1795.9815.410.624
HCT (%)29.154.8429.604.710.437
PLT (109 l-1)234.14110.26225.3388.610.486
PCT (%)0.330.400.190.150.187
Coagulation
PT (s)14.021.2014.481.990.233
PT% (%)88.5411.5485.5916.740.170
INR (R)1.090.091.130.200.420
FIB (g l-1)15.101.114.701.260.029
APTT (s)40.045.3440.045.860.925
DDi (ng l-1 FEU)15.94.074.253.980.003
Others
TnT (μg l-1)28.08280.692.542.940.521
BNP (pg m l-1)1187.98286.26340.96457.100.009
NTProBNP (pg m l-1)1250.661361.231067.311920.330.233
hsCRP (mg l-1)184.7146.7160.3940.720.002
ERS (mm h-1)52.7829.4951.2169.590.214